GLP-1 Agonists Can Affect Mood: A Case of Worsened Depression on Ozempic (Semaglutide).

Manoharan, Senthil Vel Rajan Rajaram et al.·Innovations in clinical neuroscience·2024·

Quick Facts

Study Type

Not classified

Evidence

Not graded

Sample

Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:: GLP-1 Agonists Can Affect Mood: A Case of Worsened Depression on Ozempic (Semaglutide).
Published In:: Innovations in clinical neuroscience, 21(4-6), 25-26 (2024)
Authors:: Manoharan, Senthil Vel Rajan Rajaram, Madan, Rohit
Database ID:: RPEP-08811

Evidence Hierarchy

Meta-Analysis / Systematic Review

Randomized Controlled Trial

Cohort / Case-Control

Cross-Sectional / ObservationalSnapshot without intervening

This study

Case Report / Animal Study

What do these levels mean? →

Cite This Study

RPEP-08811·https://rethinkpeptides.com/research/RPEP-08811

APA

Manoharan, Senthil Vel Rajan Rajaram; Madan, Rohit. (2024). GLP-1 Agonists Can Affect Mood: A Case of Worsened Depression on Ozempic (Semaglutide).. Innovations in clinical neuroscience, 21(4-6), 25-26.

MLA

Manoharan, Senthil Vel Rajan Rajaram, et al. "GLP-1 Agonists Can Affect Mood: A Case of Worsened Depression on Ozempic (Semaglutide).." Innovations in clinical neuroscience, 2024.

RethinkPeptides

RethinkPeptides Research Database. "GLP-1 Agonists Can Affect Mood: A Case of Worsened Depressio..." RPEP-08811. Retrieved from https://rethinkpeptides.com/research/manoharan-2024-glp1-agonists-can-affect

Access the Original Study

View on PubMed

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.

← Back to Research Database